Gene Solutions' SPOT-MAS wins FDA Breakthrough Device status
July 22, 2026 | 09:16
Gene Solutions announced its SPOT-MAS 10 multi-cancer screening test received Breakthrough Device Designation from the US FDA, advancing the biotechnology company's genomic cancer detection technology toward accelerated regulatory review.
Mobile Version